RDNT

RadNet, Inc.

59
Fundamentals64/ 100
Valuation50/ 100
Upside potential58/ 100
Risk potential24/ 100

RDNT lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover, though they disagree widely on how much.

RDNT Fundamentals

MetricStatus
Healthy
Under pressure
Healthy
Stable

RDNT's revenue and cash flow are currently healthy, and its balance sheet is stable, but its profitability is under pressure.

RDNT PE Valuation

RDNT has no meaningful PE right now: it lost money over the past year.

RDNT Forward outlook

MetricOutlook
--
Strong growth
Growth
Stable
Limited
Low

Analysts expect earnings and revenue growth for RDNT, with profitability holding steady. However, they disagree widely on these estimates.

RDNT Risk to reward

ScenarioChangePrice
Upside+33%$101.09
Downside-24%$57.59

Calculated from the latest close: $76.04 on Nov 12.

RDNT's one-year upside scenario is somewhat larger than its downside: +33% against −24%.

RDNT Earnings Per Share

Q4 2023: $0.05Q1 2024: $0.37Q2 2024: $0.21Q3 2024: $0.00Q4 2024: $0.04Q1 2025: $-0.43Q2 2025: $-0.20Q3 2025: $-0.17Q4 2025: $-0.25Q1 2026: $-0.17Q2 2026: $-0.26Q3 2026: $-0.28Forward: $0.67
Q4 2023: $0.05Q1 2024: $0.37Q2 2024: $0.21Q3 2024: $0.00Q4 2024: $0.04Q1 2025: $-0.43Q2 2025: $-0.20Q3 2025: $-0.17Q4 2025: $-0.25Q1 2026: $-0.17Q2 2026: $-0.26Q3 2026: $-0.28Forward: $0.67
QuarterTTM EPSYoY
Forward$0.67—
Q3 2026-$0.28-$0.11
Q2 2026-$0.26-$0.06
Q1 2026-$0.17+$0.26
Q4 2025-$0.25-725%
Q3 2025-$0.17-$0.17
Q2 2025-$0.20-195%
Q1 2025-$0.43-216%
Q4 2024$0.04-20%

RDNT is still losing money, but less than at its worst: $0.28 per share over the past year, against $0.43 at its worst in early 2025.

RDNT Quarterly Revenue

Q4 2023: $420MQ1 2024: $432MQ2 2024: $460MQ3 2024: $461MQ4 2024: $477MQ1 2025: $471MQ2 2025: $498MQ3 2025: $523MQ4 2025: $548MQ1 2026: $576MQ2 2026: $623MQ3 2026: $638M
Q4 2023: $420MQ1 2024: $432MQ2 2024: $460MQ3 2024: $461MQ4 2024: $477MQ1 2025: $471MQ2 2025: $498MQ3 2025: $523MQ4 2025: $548MQ1 2026: $576MQ2 2026: $623MQ3 2026: $638M
QuarterRevenueYoY
Q3 2026$638.3M+22%
Q2 2026$622.7M+25%
Q1 2026$575.6M+22%
Q4 2025$547.7M+15%
Q3 2025$522.9M+13%
Q2 2025$498.2M+8.4%
Q1 2025$471.4M+9.2%
Q4 2024$477.1M+13%

RDNT's revenue has grown year over year every quarter since late 2020: $638M last quarter, up 22% from the same quarter a year ago.

RDNT Free Cash Flow

Q4 2023: $49MQ1 2024: −$40MQ2 2024: $69MQ3 2024: $16MQ4 2024: −$377,000Q1 2025: −$7MQ2 2025: $67MQ3 2025: −$8MQ4 2025: $33MQ1 2026: $9MQ2 2026: $38MQ3 2026: $35M
Q4 2023: $49MQ1 2024: −$40MQ2 2024: $69MQ3 2024: $16MQ4 2024: −$377,000Q1 2025: −$7MQ2 2025: $67MQ3 2025: −$8MQ4 2025: $33MQ1 2026: $9MQ2 2026: $38MQ3 2026: $35M
QuarterFree cash flowYoY
Q3 2026$35.1M+$42.7M
Q2 2026$37.8M-44%
Q1 2026$9M+$16.4M
Q4 2025$33.1M+$33.5M
Q3 2025-$7.6M-147%
Q2 2025$67.4M-2.8%
Q1 2025-$7.4M+$33M
Q4 2024-$377K-101%

RDNT generated $115M in free cash flow over the past year, up 121% from the year before.

RDNT Total Shares

Q4 2023: 65MQ1 2024: 69MQ2 2024: 73MQ3 2024: 75MQ4 2024: 75MQ1 2025: 74MQ2 2025: 76MQ3 2025: 77MQ4 2025: 75MQ1 2026: 77MQ2 2026: 79MQ3 2026: 79M
Q4 2023: 65MQ1 2024: 69MQ2 2024: 73MQ3 2024: 75MQ4 2024: 75MQ1 2025: 74MQ2 2025: 76MQ3 2025: 77MQ4 2025: 75MQ1 2026: 77MQ2 2026: 79MQ3 2026: 79M
PeriodChange %Net change
Quarterly+0.6%+443K shares
1 year+2.3%+1.8M shares
3 years+15%+10.4M shares
5 years+47%+25.4M shares
Available history+57%+28.9M shares

RDNT has 79M diluted shares, up 2.3% from a year ago.

RDNT Net Leverage

Q4 2023: 2.2xQ1 2024: 1.3xQ2 2024: 1.2xQ3 2024: 1.1xQ4 2024: 1.1xQ1 2025: 1.4xQ2 2025: 1.3xQ3 2025: 1.4xQ4 2025: 1.5xQ1 2026: 2.8xQ2 2026: 2.5xQ3 2026: 2.3x
Q4 2023: 2.2xQ1 2024: 1.3xQ2 2024: 1.2xQ3 2024: 1.1xQ4 2024: 1.1xQ1 2025: 1.4xQ2 2025: 1.3xQ3 2025: 1.4xQ4 2025: 1.5xQ1 2026: 2.8xQ2 2026: 2.5xQ3 2026: 2.3x
QuarterNet LeverageStatus
Q3 20262.3xModerate
Q2 20262.5xModerate
Q1 20262.8xModerate
Q4 20251.5xHealthy
Q3 20251.4xHealthy
Q2 20251.3xHealthy
Q1 20251.4xHealthy
Q4 20241.1xHealthy

RDNT's net debt is about 2.3 years of its operating earnings (EBITDA), up from 1.4 years a year ago.

RDNT Weekly Momentum

MetricValueStatus
RSI60.3Neutral
Stochastic65.1Neutral

RDNT's weekly RSI is 60 (neutral) and its Stochastic is 65 (neutral).

RDNT PE vs Healthcare Sector

MetricRDNTSector medianRelative
PEN/A26x—

RDNT has no meaningful PE right now: it lost money over the past year.

RDNT Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$72.05.6% above
20 week MA$71.26.8% above
50 week MA$66.814% above
100 week MA$65.117% above
200 week MA$54.240% above

RDNT is in an uptrend: it's above all five of its weekly moving averages, and 40% above its 200-week average.

RDNT Yearly ROI

YearStart priceEnd priceROI
2020$19.9$18.7-5.8%
2021$18.7$30.4+62%
2022$30.4$18.9-38%
2023$18.9$34.8+84%
2024$34.8$71.3+105%
2025$71.3$73.2+2.6%
2026 YTD$73.2$76.0+4%

RDNT has finished higher in four of the last six years, three of them by more than 50%. It's up 4% so far in 2026.

Give your agent the market.

Get API key